Stocks
GlaxoSmithKline (GSK) FCF US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| FCF, £ | ? | 5 145 000 000 | 4 004 000 000 | 6 257 522 970 | 3 572 000 000 | 5 824 498 768 | 6 236 295 705 | ||
| Changes by years, y/y, % | 0% | -22% | +56% | -43% | +63% | -2.2% | |||
GlaxoSmithKline. FCF, £
GlaxoSmithKline. FCF, changes, %
GlaxoSmithKline. FCF, sum by quarters, £
GlaxoSmithKline (GSK) FCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| FCF, £ | ? | 697 000 000 | 1 463 000 000 | 2 599 208 130 | 1 476 087 575 | 698 000 000 | 6 236 295 705 | |
| Changes by years, y/y, % | +85% | +233% | +98% | +24% | +0% | |||
| Changes by quarters, q/q, % | -42% | +110% | +78% | -43% | -53% | |||
